The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $188.30

Today's change+0.39 +0.21%
Updated September 22 4:01 PM EDT. Delayed by at least 15 minutes.
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $188.30

Today's change+0.39 +0.21%
Updated September 22 4:01 PM EDT. Delayed by at least 15 minutes.

Thermo Fisher Scientific Inc up (U.S.)$0.39

Thermo Fisher Scientific Inc closed up Friday by (U.S.)$0.39 or 0.21% to (U.S.)$188.30. Shares have lost 1.22% over the last five days, but sit 3.09% below their 52-week high. This security has outperformed the S&P 500 by 4.50% during the last year.

Key company metrics

  • Open(U.S.) $188.13
  • Previous close(U.S.) $187.91
  • High(U.S.) $189.11
  • Low(U.S.) $187.31
  • Bid / Ask-- / --
  • YTD % change+33.45%
  • Volume912,198
  • Average volume (10-day)1,447,959
  • Average volume (1-month)1,475,682
  • Average volume (3-month)1,386,460
  • 52-week range(U.S.) $139.07 to (U.S.) $194.30
  • Beta1.05
  • Trailing P/E32.80×
  • P/E 1 year forward20.18×
  • Forward PEG1.72×
  • Indicated annual dividend(U.S.) $0.60
  • Dividend yield0.32%
  • Trailing EPS(U.S.) $5.74
Updated September 22 4:01 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJul 01, 201707/01/2017Apr 01, 201704/01/2017Dec 31, 201612/31/2016Oct 01, 201610/01/2016
Revenue4,9904,7654,9534,491
Total other revenue--------
Total revenue4,9904,7654,9534,491
Gross profit2,2832,1932,2792,054
Total cost of revenue2,7072,5732,6742,437
Total operating expense4,2394,1434,2013,950
Selling / general / administrative1,2811,3001,2571,212
Research & development222215213183
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)295557117
Other operating expenses, total--------
Operating income752622753541
Interest income (expense), net non-operating-134-135-131-113
Gain (loss) on sale of assets--------
Other--------
Income before tax626503652428
Income after tax612551633474
Income tax, total13-4919-46
Net income612551630474
Total adjustments to net income--------
Net income before extra. items612551633474
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items612551633474
Inc. avail. to common incl. extra. items612551630474
Diluted net income612551630474
Dilution adjustment--------
Diluted weighted average shares393394397397
Diluted EPS excluding extraordinary itemsvalue per share1.561.401.591.19
Dividends per sharevalue per share0.150.150.150.15
Diluted normalized EPSvalue per share1.631.491.981.38